Related Experiment Videos
Peripheral neuropathy in systemic lupus erythematosus--a longitudinal study
R Omdal1, S Løseth, T Torbergsen
1Department of Clinical Medicine/Neurology, University Hospital of Tromsø, Oslo, Norway. romdal@online.no
Acta Neurologica Scandinavica
|June 26, 2001
Summary
Systemic lupus erythematosus (SLE) patients show a modest progressive peripheral neuropathy (PN). Nerve conduction velocity (NCV) abnormalities can fluctuate and are not always irreversible, with no clear association to disease factors.
Area of Science:
- Neurology
- Rheumatology
- Clinical Neurophysiology
Background:
- Peripheral neuropathy (PN) affects 5-27% of patients with systemic lupus erythematosus (SLE).
- PN in SLE typically presents as a length-dependent sensorimotor axonopathy.
- Longitudinal studies on the progression of PN in SLE patients are limited.
Purpose of the Study:
- To investigate the longitudinal progression of peripheral neuropathy in patients with systemic lupus erythematosus (SLE).
- To assess changes in nerve conduction velocity (NCV) parameters over a 7-year period.
- To identify factors associated with the progression of PN in SLE.
Main Methods:
- A longitudinal study involving 33 Caucasian SLE patients.
- Clinical examination, laboratory tests, and nerve conduction velocity (NCV) studies were performed at baseline and after 7 years.
- Twenty patients completed the 7-year follow-up for NCV analysis.
Main Results:
- At follow-up, 33% of NCV parameters showed significant deterioration over time.
- NCV changes were dependent on baseline levels, indicating a potential autoregressive process.
- No demographic, laboratory, or disease-associated factors were consistently linked to NCV changes over time.
Conclusions:
- A modest progressive neuropathic process is present in SLE patients.
- Abnormalities in NCV parameters can fluctuate in individuals and are not necessarily irreversible.
- No association was found between PN progression and medication, demographic, or other disease-associated factors.